Clinical Guides
Chronic Heart Failure
A clinically focused, India-facing guide to recognising chronic heart failure, confirming its phenotype, using monitored disease-modifying care and escalating deterioration safely.
MedNext Academy | 12 min read
Chronic Heart Failure
A clinically focused, India-facing guide to recognising chronic heart failure, confirming its phenotype, using monitored disease-modifying care and escalating deterioration safely.
Summary
Chronic heart failure is a clinical syndrome in which a structural or functional cardiac abnormality causes symptoms or signs from inadequate output, raised filling pressures, or both. Breathlessness, fatigue, oedema and reduced exercise capacity are important but not specific. Classification by left-ventricular ejection fraction guides evidence-based treatment: reduced ejection fraction, mildly reduced ejection fraction and preserved ejection fraction have different trial evidence, while every patient still needs a search for cause, congestion, comorbidity and reversible precipitants.
Diagnosis is not made from ankle swelling, an ECG, a chest radiograph or a natriuretic peptide alone. It combines history, examination, ECG, laboratory assessment, natriuretic peptide testing where available and echocardiography. A normal or low peptide makes heart failure less likely in an untreated person, but obesity and prior diuretics or disease-modifying drugs can lower values. Kidney disease, atrial fibrillation, sepsis and pulmonary disease can elevate values.
Care is longitudinal: education, vaccination where appropriate, volume assessment, rehabilitation, cause-directed treatment, disease-modifying therapy where indicated and a written plan for deterioration. Acute pulmonary oedema, shock, syncope, new confusion or severe hypoxia are emergencies. This educational draft does not replace individual prescribing, Indian labels, local formularies or cardiology assessment.
How Common Is It?
Heart failure is a major cause of hospitalisation and disability worldwide, but a single global or Indian percentage is misleading. Burden changes with age structure, hypertension, diabetes, coronary disease, rheumatic and valvular disease, cardiomyopathy, survival after myocardial infarction, access to echocardiography and whether surveys count symptoms, hospital admissions or established diagnoses. People with preserved ejection fraction may be undercounted when diagnostic testing is limited.
India has wide regional differences in cardiovascular risk, rural access, affordability of medicines and availability of specialist services. Clinic registries and tertiary hospital cohorts often describe younger or sicker patients than the community, so they cannot be presented as national prevalence. Conversely, administrative records may miss people managed in primary care or using multiple facilities. Honest reporting identifies population, year, diagnostic definition and data source.
For a clinician, prevalence should not determine whether a breathless person is investigated. Heart failure is common enough to consider in older people and in those with coronary disease, hypertension, diabetes, valve disease, congenital heart disease, cardiomyopathy or cardiotoxic therapy, but dyspnoea may also arise from anaemia, lung disease, obesity, renal failure, deconditioning or infection. Service planning should track admissions, mortality, medication access, renal monitoring, rehabilitation attendance and readmissions rather than promising a precise number unsupported by local data.
Risk Factors
Coronary artery disease, previous myocardial infarction, long-standing hypertension, diabetes, valve disease, atrial fibrillation, cardiomyopathy, myocarditis, congenital heart disease and infiltrative disease are important causes or contributors. Alcohol excess, cardiotoxic chemotherapy, uncontrolled thyroid disease, chronic kidney disease, sleep-disordered breathing and severe anaemia may worsen myocardial function or volume status. Family history can matter in inherited cardiomyopathy, but it is not a substitute for phenotyping relatives or arranging specialist genetic assessment when indicated.
Risk is cumulative. A person with hypertension and diabetes may develop heart failure despite no obvious acute event, while a patient with valvular disease may deteriorate after infection or arrhythmia. Pregnancy-related cardiomyopathy, rheumatic heart disease and untreated congenital lesions remain relevant in India but should not be assumed from geography alone. Ask about salt-containing remedies, non-steroidal anti-inflammatory drugs, corticosteroids, over-the-counter combinations, stimulant use and adherence, because some medicines promote fluid retention or renal injury.
A precipitant is not always the underlying cause. Infection, anaemia, arrhythmia, acute coronary syndrome, uncontrolled blood pressure, renal dysfunction, missed medicines and excess dietary sodium can cause decompensation in established heart failure. The assessment should separate modifiable contributors from conditions that need urgent specialist treatment. Smoking cessation, physical activity matched to stability, diabetes and blood-pressure control, immunisation and weight management are preventive care, but no lifestyle advice replaces evidence-based medicine or intervention for a correctable valve or coronary lesion.
Diagnosis
History
Establish exertional and resting breathlessness, orthopnoea, paroxysmal nocturnal dyspnoea, fatigue, reduced exercise tolerance, ankle swelling, weight change, abdominal fullness, palpitations, chest pain and syncope. Ask onset, progression, baseline function, admission history, fluid and salt intake, medicines, alcohol, pregnancy, infection and adherence. Identify coronary, valve, hypertensive, renal, endocrine and cardiomyopathy history. A daily weight record can reveal congestion but does not diagnose its cause.
Examination
Measure pulse, blood pressure, oxygen saturation, weight and perfusion. Look for raised jugular venous pressure, pulmonary crackles, oedema, ascites, displaced apex, third heart sound, murmurs, irregular rhythm and signs of alternative disease. Cold peripheries, hypotension, altered mentation or oliguria suggest hypoperfusion and require urgent escalation. Absence of oedema does not exclude heart failure, particularly after diuretics or in predominantly left-sided disease.
Investigations
Current guidelines recommends NT-proBNP for suspected chronic heart failure and transthoracic echocardiography to assess ventricular and valve function. ECG, chest radiograph and blood tests including renal function, electrolytes, full blood count, liver and thyroid tests help define cause, safety and mimics. Very high NT-proBNP needs urgent specialist assessment under current guidelines thresholds, but thresholds are not automatically Indian referral rules. Echocardiography identifies ejection fraction and important valve disease; targeted ischaemia, rhythm, cardiac MRI or genetic assessment follows the clinical question.
Differential Diagnosis
Breathlessness and oedema demand broad reasoning. Chronic obstructive pulmonary disease, asthma, pneumonia, pulmonary embolism, interstitial lung disease, obesity, deconditioning, anxiety, anaemia, renal disease, liver disease, venous insufficiency and drug-related oedema may mimic or coexist with heart failure. A high natriuretic peptide supports cardiac stress but may occur with renal dysfunction, sepsis, atrial fibrillation and pulmonary disease; a low value is less reliable in obesity or after treatment.
Valve disease, constrictive pericarditis, restrictive or infiltrative cardiomyopathy, pulmonary hypertension and high-output states can produce a heart-failure syndrome but need different treatment. A murmur, low voltage, disproportionate right-heart signs, marked proteinuria, systemic inflammatory features or recurrent unexplained syncope should prevent reflex treatment as generic HFrEF. A patient with chest pain, new ECG change or troponin rise needs evaluation for acute coronary syndrome rather than outpatient titration.
Differentiate stable chronic symptoms from acute decompensation. Rapid weight gain, resting dyspnoea, hypoxia, pulmonary oedema, hypotension, new confusion, reduced urine, syncope or escalating diuretic requirement are warning signs. In India, tuberculosis, rheumatic disease, anaemia and untreated hypertension may be relevant depending on history, but broad labels are not diagnoses. The safest differential combines an emergency screen, echo phenotype, volume assessment and cause-directed testing rather than relying on response to a diuretic.
Management
Management starts with confirming phenotype, cause, congestion and priorities. Refer or co-manage with a heart-failure multidisciplinary team when possible. Give a written care plan that covers medicines, monitoring, weight or symptom change, rehabilitation, vaccination, diet, activity, follow-up and whom to contact. Encourage exercise-based cardiac rehabilitation only after assessment of suitability; advice should be accessible and include education and psychological support. Restrictive diets or fluid targets should be individualised rather than copied blindly.
For HFrEF, current guidelines (2025) recommends an ACE inhibitor, evidence-based beta-blocker, mineralocorticoid receptor antagonist and SGLT2 inhibitor when appropriate, then consideration of ARNI in symptomatic people at maximally tolerated core therapy. Loop diuretics relieve congestion but are not a substitute for disease-modifying treatment. HFmrEF and HFpEF require careful attention to congestion, blood pressure, atrial fibrillation, ischaemia, diabetes, obesity, renal disease and valvular disease; SGLT2-inhibitor recommendations have evolving evidence and local access must be checked.
Review frequently during initiation and after illness or medicine change. Monitor blood pressure, pulse, renal function, potassium, symptoms and adherence. Treat coronary, valve, rhythm or infiltrative causes when identified. Consider device therapy, revascularisation, valve intervention, advanced therapies or palliative care through specialists. Avoid routine long-term home oxygen solely for heart failure. Worsening symptoms need rapid assessment; a patient should not self-escalate drugs or stop disease-modifying therapy without a written clinician plan.
Prescribing Information
Disease-modifying therapy must be introduced and titrated with blood pressure, renal function, potassium, heart rate, volume status and interactions in view. ACE inhibitors, ARBs and ARNIs can cause hypotension, renal-function change, hyperkalaemia and angioedema. An ARNI must not overlap with an ACE inhibitor; the washout and switching plan belongs to the prescriber. Beta-blockers should be started when clinically stable, not newly initiated during shock or uncontrolled congestion without specialist direction. MRAs require potassium and renal monitoring.
SGLT2 inhibitors may be used in people with or without diabetes but have genital-infection, volume-depletion and rare ketoacidosis risks; sick-day and perioperative guidance is individualised. Diuretics require daily symptom, weight, renal and electrolyte review, especially with vomiting, diarrhoea, poor intake or NSAID use. Digoxin, antiarrhythmics, anticoagulants, ivabradine, intravenous iron and vasodilators each have specific indications and monitoring; do not treat them as interchangeable heart-failure tablets.
Avoid NSAIDs where possible because they can cause sodium retention, renal injury and decompensation. Check herbal, salt substitutes and potassium products. Pregnancy, breastfeeding, advanced kidney disease, severe liver disease, frailty and hypotension require specialist selection. Indian product approvals, strengths, cost and monitoring pathways differ; confirm current CDSCO labelling and local formulary. This guide intentionally gives no dose schedule. A medicines list, clear ownership of titration and early laboratory follow-up are safer than a generic prescription copied from a guideline.
When to Refer
Refer suspected heart failure for echocardiography and specialist assessment according to local capacity, urgently when natriuretic peptide is very elevated or symptoms are severe. Cardiology input is important for new HFrEF, uncertain phenotype, suspected cardiomyopathy, significant valve disease, congenital disease, recurrent admission, syncope, ventricular arrhythmia, persistent angina, advanced kidney disease or inability to tolerate core therapy. Refer early for pregnancy-associated symptoms, family history of sudden cardiac death or unexplained cardiomyopathy.
Emergency referral is needed for acute pulmonary oedema, severe resting breathlessness, oxygen requirement, shock, hypotension, altered consciousness, chest pain suggesting acute coronary syndrome, sustained arrhythmia, syncope, stroke symptoms or rapidly falling urine output. Do not delay transfer to arrange an outpatient natriuretic peptide. Ophthalmic, respiratory, renal, diabetes, geriatrics, palliative and rehabilitation services may be needed alongside cardiology depending on the clinical problem.
In India, travel distance, public-sector waiting time, private cost and availability of echo, devices and advanced therapies affect plans. Name a reachable centre, emergency route and interim clinician. Refer to social work or financial counselling where available, because affordability directly affects adherence. A clinician should state what is uncertain and what monitoring is possible locally rather than promise a device, transplant, infusion or specialist drug. Palliative-care referral is appropriate for symptom support and advance-care planning and does not mean abandoning disease-directed care.
Red Flags
Call emergency services or arrange urgent hospital assessment for severe breathlessness at rest, pink frothy sputum, cyanosis, new confusion, collapse, syncope, cold clammy skin, systolic hypotension, chest pain, sustained palpitations, new focal neurological deficit or markedly reduced urine. These can indicate acute pulmonary oedema, cardiogenic shock, myocardial infarction, dangerous arrhythmia or another emergency. A rapid rise in weight with oedema or abdominal distension also deserves same-day review, particularly when accompanied by reduced exercise tolerance or poor response to the existing diuretic plan.
Medication red flags include facial or tongue swelling after a renin-angiotensin drug, severe dizziness, fainting, symptomatic bradycardia, severe diarrhoea or vomiting, black stools, confusion, muscle weakness or palpitations suggesting electrolyte disturbance. Patients should not stop all cardiac medicines independently, but must seek urgent prescriber advice. NSAID exposure, infection, missed medicines, high salt intake and new arrhythmia are common triggers for deterioration and should be actively sought.
New heart-failure symptoms in pregnancy or postpartum, with fever, after chemotherapy, with a new murmur, or in a young person with family history of sudden death demand urgent cause-directed evaluation. Severe depression, cognitive decline, inability to obtain medicines, repeated falls or caregiver collapse can be clinical safety issues. The red-flag plan should be written in plain language and shared with family, including the emergency number and the facility able to provide oxygen, ECG, imaging and intravenous treatment.
Indian Clinical Context
International ESC and international guidelines guidance is evidence-based but does not define Indian licensing, reimbursement, referral thresholds or access. India has mixed public and private systems with unequal availability of natriuretic peptides, echocardiography, coronary intervention, devices, rehabilitation and specialist nursing. Use the local hospital pathway, current CDSCO labelling and available laboratory monitoring. Do not report a European trial population or a tertiary Indian registry as the experience of every Indian patient.
Common causes and priorities can differ between individuals and regions: hypertension, diabetes, coronary disease, rheumatic valve disease, cardiomyopathy, anaemia, infection and kidney disease need direct assessment. Low-cost fixed-dose combinations or unregulated supplements may obscure ingredients, while travel and out-of-pocket costs may interrupt titration. A realistic plan schedules renal and potassium checks before increasing medicines and offers a public referral route if branded therapy is unaffordable. Medication sharing and abrupt discontinuation should be discussed without blame.
NMC-based education supports focused examination, rational prescribing, communication and referral, but precise codes must be verified against the adopted institutional curriculum. Explain uncertainty honestly: the best sequence of therapy, device eligibility and home monitoring depends on phenotype, laboratory capacity and local specialist advice. This guide is a quarantined educational draft, has been reviewed by the MedNext Clinical Team; it does not claim Indian national guideline endorsement or replace urgent emergency care.
NMC Competency Mapping
Chronic heart failure integrates medicine, pharmacology, cardiology, emergency care, rehabilitation and communication. Learners should identify congestion and hypoperfusion, take a cardiovascular and medication history, examine jugular venous pressure and peripheral oedema, interpret ECG and chest radiograph at an introductory level, and explain why echocardiography and natriuretic peptides answer different questions. They should distinguish a stable outpatient from acute decompensation and formulate safe referral rather than inventing a single competency code.
At Know and Know How level, students describe HFrEF, HFmrEF and HFpEF, major causes, precipitating factors and the purpose of diuretics versus disease-modifying therapy. At Show How level, they counsel about daily symptoms, medicine adherence, NSAID avoidance, red flags and laboratory monitoring; create a shared care plan; and communicate risk sensitively to family. Drug initiation and titration remain supervised tasks because renal function, potassium and haemodynamics can change rapidly.
Assessment can use a patient with orthopnoea, oedema and hypertension, asking for differential diagnosis, first investigations, echo interpretation, urgency and a monitoring plan. A second vignette with shock or syncope tests escalation. Professionalism means addressing affordability, literacy, sex and pregnancy concerns, disability and palliative needs without rationing care by assumption. Consult current NMC regulations and local curriculum for formal code-level mapping and expected supervised performance.
Key Exam Pearls for NEET PG
Heart failure is a syndrome, not an ejection-fraction number. Confirm symptoms and signs with investigations, then phenotype by echocardiography. NT-proBNP is useful for suspected chronic heart failure; a high level has alternative causes and a low level may be falsely reassuring in obesity or treated disease. Current guidelines uses urgent and non-urgent thresholds, but questions should specify the guideline and units. Echo assesses systolic and diastolic function and important valve disease.
For HFrEF, remember the contemporary core classes: ACE inhibitor or suitable alternative, beta-blocker, MRA and SGLT2 inhibitor, with ARNI consideration in appropriate symptomatic patients. Diuretics relieve congestion but do not replace disease-modifying therapy. Monitor renal function, potassium, pulse and blood pressure. Avoid NSAIDs because they can worsen fluid retention and kidney function. Do not combine an ACE inhibitor and ARNI without the required prescriber-led switching plan.
Orthopnoea, paroxysmal nocturnal dyspnoea, raised JVP, crackles and oedema suggest congestion; hypotension, cold extremities, confusion and oliguria suggest hypoperfusion. Acute pulmonary oedema, shock, chest pain, syncope and sustained arrhythmia are emergencies. Differential diagnoses include lung disease, anaemia, renal disease and valvular pathology. Rehabilitation, multidisciplinary care, cause treatment and palliative support are integral, not optional extras.
Frequently Asked Questions
Can an echocardiogram alone diagnose chronic heart failure?
No. Echocardiography defines ventricular and valve structure and ejection fraction, but heart failure remains a clinical syndrome requiring symptoms or signs, examination and context. A normal ejection fraction does not automatically exclude HFpEF, and an abnormal ejection fraction can be asymptomatic. Natriuretic peptides, ECG, laboratory results and assessment for alternative causes complete a safe diagnostic pathway.
Why are kidney tests and potassium checked so often?
Many heart-failure medicines affect renal blood flow, potassium or volume status. ACE inhibitors, ARBs, ARNIs, MRAs, diuretics and SGLT2 inhibitors each need individual monitoring, particularly during dose changes, dehydration, infection or NSAID exposure. Small laboratory changes can be expected, but significant hyperkalaemia, worsening kidney function or symptomatic hypotension needs prompt prescriber review rather than self-adjustment.
Should every person with chronic heart failure use home oxygen?
No. Long-term home oxygen is not routinely offered solely for advanced heart failure. Oxygen may be prescribed for a separate documented indication, such as some chronic lung diseases, using an individual assessment. New severe breathlessness or low oxygen level is an emergency assessment issue, not a reason to obtain improvised oxygen equipment at home.
Is chronic heart failure treatment identical across India?
No. International evidence guides care, but Indian product licences, public and private formularies, affordability, testing and specialist access differ. The treating team should provide a plan that matches the patient’s phenotype, kidney function, blood pressure, pregnancy status and local monitoring capacity. This guide cannot replace a named cardiology and emergency pathway.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic